Basit öğe kaydını göster

dc.contributor.authorJabeen, Saima
dc.contributor.authorFarooqi, Ammad Ahmad
dc.contributor.authorIsmail, Muhammad
dc.contributor.authorIqbal, Muhammad Javed
dc.contributor.authorJaved, Zeeshan
dc.contributor.authorQureshi, Muhammad Zahid
dc.date.accessioned2022-02-18T10:27:12Z
dc.date.available2022-02-18T10:27:12Z
dc.date.issued2016
dc.identifier.citationJabeen S., Qureshi M. Z. , Javed Z., Iqbal M. J. , Ismail M., Farooqi A. A. , "Kisspeptin Mediated Signaling in Cancer", CURRENT TOPICS IN MEDICINAL CHEMISTRY, cilt.16, sa.22, ss.2471-2476, 2016
dc.identifier.issn1568-0266
dc.identifier.othervv_1032021
dc.identifier.otherav_9d1727f2-f868-47ca-ac01-f02c293bf0f5
dc.identifier.urihttp://hdl.handle.net/20.500.12627/179263
dc.identifier.urihttps://doi.org/10.2174/1568026616666160212123309
dc.description.abstractResearch over the years has gradually and sequentially highlighted contributory role of hypothalamic- based kisspeptin-signaling axis as a major positive modulator of the neuroendocrinological reproductive axis in mammals. However, a series of landmark studies provided convincing evidence of role of this signaling in regulation of cancer development and progression. It is becoming progressively more understandable that loss or reduction of KISS1 expression in different human cancers correlates inversely with progression of tumor, metastasizing potential and survival. In this review we have attempted to provide an overview highlight of the most recent updates addressing metastasis-suppressing role of KISS1. We also summarize interplay of microRNA and KISS1 in cancer. The miRNA regulation of different genes is a rapidly expanding area of research however, the community lacks a deep understanding of miRNA regulation of KISS1. Recently, emerging laboratory findings have shown that KISS1 is transcriptionally controlled by TCF21 that is in turn regulated by miR-21. Therefore, there is an urgent need for further study of how miRNA directly or indirectly influences KISS1 at the posttranscriptional level. There is also a lack of evidence regarding natural agents that mediate upregulation or downregulation of KISS1. Increasing the knowledge of the KISS1/KISS1R signaling axis will be helpful in achieving personalized medicine.
dc.language.isoeng
dc.subjectTemel Bilimler
dc.subjectPharmacology
dc.subjectPharmacology, Toxicology and Pharmaceutics (miscellaneous)
dc.subjectPharmacy
dc.subjectGeneral Pharmacology, Toxicology and Pharmaceutics
dc.subjectChemistry (miscellaneous)
dc.subjectGeneral Chemistry
dc.subjectPharmacology (medical)
dc.subjectDrug Guides
dc.subjectPhysical Sciences
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectKİMYA, TIP
dc.subjectKimya
dc.subjectTemel Bilimler (SCI)
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectSağlık Bilimleri
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectBiyokimya
dc.titleKisspeptin Mediated Signaling in Cancer
dc.typeMakale
dc.relation.journalCURRENT TOPICS IN MEDICINAL CHEMISTRY
dc.contributor.departmentArid Agriculture University , ,
dc.identifier.volume16
dc.identifier.issue22
dc.identifier.startpage2471
dc.identifier.endpage2476
dc.contributor.firstauthorID3383815


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster